A novel human glucocorticoid receptor SNP results in increased transactivation potential()

Glucocorticoids are one of the most widely used therapeutics in the treatment of a variety of inflammatory disorders. However, it is known that there are variable patient responses to glucocorticoid treatment; there are responders and non-responders, or those that need higher dosages. Polymorphisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Tajia L., Tung, Kelly, Lim, Debora, Leventhal, Stacey M., Cho, Kiho, Greenhalgh, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614576/
https://www.ncbi.nlm.nih.gov/pubmed/28955999
http://dx.doi.org/10.1016/j.bbrep.2016.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614576/
https://www.ncbi.nlm.nih.gov/pubmed/28955999
http://dx.doi.org/10.1016/j.bbrep.2016.12.003

Ejemplares similares